BioTel Research is proposing a service offering for evaluation of cardiac repolarization in early human trials, novel to the industry, called Dynamic Repolarization Analysis.

In this free webinar, industry experts Edward Ashton, PhD and Polina Voloshko, MD will discuss the growing range of imaging modalities and analysis methods that are available for use in your clinical trials during oncology drug development.

Join Svetlana Kolchinsky, Director of Project Operations, as she discusses how to manage multi-protocol programs and build efficiencies while being a good partner. Key topics include next level planning for risk management and project/program oversight, successful project delivery and lessons learned.

In this free webinar, BioTel Research’s Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, present alternative, noninvasive imaging methods to determine body composition. Watch Webinar

In this free webinar, Polina Voloshko, MD, Chief Medical Officer and Daniel Goodman, MD, Vice President and Medical Director, present the updates from the 2017 CSRC/FDA meeting on cardiac safety and cardiovascular safety issues in oncology drug development to optimize your clinical trial.

In this free webinar, Ed Ashton, PhD, Vice President of Oncology Imaging and Danielle Lewis, MS, PMP, Global Operations Account Manager, present real-world scientific and operational examples of errors that can occur during your imaging clinical trial and how you can prevent them.

In this free webinar, Richard Ehman, MD from the Mayo Clinic and BioTel Research’s Jonathan Riek, PhD, VP, Musculoskeletal and Metabolic Imaging discuss non-invasive ways to assess NASH using imaging, including proton density fat fraction (PDFF), T1 relaxometry, magnetic resonance elastography (MRE), and the latest advances in MRE.